文献速递结核与非结核分枝杆菌

利福喷丁在儿童中的药代动力学与安全性:潜伏性结核感染的给药方案

Pharmacokinetics and safety of rifapentine in children: dosing for latent tuberculosis infection.
PubMed 文献 · J Antimicrob Chemother · 2025-01-01

在中国10岁以下儿童中开展开放标签、前瞻性、单臂临床试验,评估每日利福喷丁-异烟肼方案的安全性,并建立药代动力学-毒性模型。模型良好描述了利福喷丁自身诱导(21天后达平台,清除率增加70.4%);模拟提示按体重给药可能导致14.5 kg以下儿童暴露不足,固定剂量策略可使血药浓度落在治疗窗内。

要点

  • 每日利福喷丁治疗耐受良好,共纳入36名0.89-10岁儿童。
  • 利福喷丁自身诱导在21天后达平台,清除率增加70.4%。
  • 模拟提示按体重给药可能使14.5 kg以下儿童暴露不足,固定剂量策略可保证血药浓度在治疗窗内。

核心结论

  • 研究提示,固定剂量利福喷丁策略对1至10岁中国儿童潜伏性结核感染治疗可能安全有效。

研究设计与样本

  • 开放标签、前瞻性、单臂临床试验,纳入 eligible 的10岁以下患者。

主要发现

  • 每日一次利福喷丁治疗耐受良好,来自36名儿童(年龄范围0.89-10岁)的310份样本(利福喷丁n=139;总胆红素n=171)被联合一室药代动力学模型与间接反应模型良好捕获。
  • 模型充分描述了利福喷丁自身诱导,21天后达平台,清除率增加70.4%。
  • 模拟提示按体重给药可能导致14.5 kg以下儿童暴露不足;固定剂量策略可确保血浆水平在治疗窗内。
  • 利福喷丁对总胆红素的影响在2倍范围内,停药后5天内效应消退。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the safety of 4-week daily rifapentine-isoniazid regimen in latent tuberculosis for Chinese children, and to provide paediatric-specific evidence for extrapolating adult dosing strategies to children. METHODS: An open-label, prospective, single-arm clinical trial was conducted among eligible patients (aged <10 years old). Rifapentine concentrations and laboratory safety biomarker (total bilirubin) were analysed and used for population pharmacokinetic-toxicity model development. Simulations were performed to compare efficacy and safety of weight-based and flat-dosing strategy. RESULTS: Once-daily rifapentine treatment was well tolerated: 310 samples (rifapentine n = 139; total bilirubin n = 171) from 36 children (age range 0.89-10 years) were captured well by a joint one-compartment pharmacokinetic with time-varying clearance and an indirect response model. The model adequately described rifapentine autoinduction, reaching a plateau after 21 days and increasing clearance by 70.4%. Simulation suggested that weight-based dosing may cause underexposure in children under 14.5 kg. A flat-dosing strategy could ensure plasma levels within the therapeutic windows. Rifapentine's impact on total bilirubin was within a 2-fold range, and the effect subsided within 5 days after discontinuation. CONCLUSIONS: Our study suggested that a flat-dosing strategy of rifapentine was potentially safe and effective for latent tuberculosis infection treatment in Chinese children aged 1 to 10 years old.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Liu W, Xu N, Li W, et al. Pharmacokinetics and safety of rifapentine in children: dosing for latent tuberculosis infection. J Antimicrob Chemother. 2025. PMID: 39945044. doi:10.1093/jac/dkaf029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。